These requirements can add $200-$500 monthly in additional healthcare costs
All three doses of orforglipron (6 mg, 12 mg, and 36 mg) met the primary and all key secondary endpoints by showing significant weight loss, meaningful A1C reductions, and improvements in cardiometabolic risk factors compared with placebo at 72 weeks
In the double-blind, randomized, placebo-controlled, dose-escalation phase 1 study of ASHMI (600 mg, 1200 mg, 1800 mg), no grade 3 adverse events occurred, laboratory parameters before and after treatment remained within normal ranges, and no unexpected immunological changes were detected, supporting its safety and tolerability allowing for advancement to phase 2 study [99]
The opposite is more likely: because obesity itself suppresses sperm production, losing weight on a GLP-1 drug tends to improve sperm concentration and motility over time
The anxious stomachdigestive upset linked to stress or anxietyis a well-known phenomenon
When asked if there are effective supplements or dietary changes to prevent weight regain post-Ozempic, Kaplan shared that no natural supplements like berberine or green tea are as effective